protoberberine has been researched along with Acute Myelogenous Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, HF; Guo, YJ; Li, ZR; Liu, HM; Liu, ZZ; Maa, M; Niu, SH; Shen, DD; Suo, FZ; Yu, B; Zhao, LJ; Zheng, YC | 1 |
1 other study(ies) available for protoberberine and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Natural protoberberine alkaloids, identified as potent selective LSD1 inhibitors, induce AML cell differentiation.
Topics: Animals; Antineoplastic Agents; Berberine Alkaloids; Cell Differentiation; Cell Survival; Female; Histone Demethylases; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mice; Mice, SCID | 2020 |